ESC 365 - Superiority of long-acting to short-acting loop diuretics in the treatment of heart failure with preserved ejection fraction: a sub-analysis of the CURE-HF Registry.

ESC Premium Access

Superiority of long-acting to short-acting loop diuretics in the treatment of heart failure with preserved ejection fraction: a sub-analysis of the CURE-HF Registry.

Session: Poster Session 1 - Treatment of the chronic heart failure

Topic: Pharmacotherapy

Speaker: Doctor S. Suzuki (Matsumoto, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Sho Suzuki

Shinshu University School of Medicine, Matsumoto (Japan)

0 follower

9 more presentations in this session

Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

Speaker: Doctor A. Kozynacka (Krakow, PL)

Effect of sacubitril-valsartan in reducing physical frailty in patients with advanced heart failure in waiting list for heart transplantation

Speaker: Doctor G. Benincasa (Naples, IT)

Use of sacubitril-valsartan in an extensive long term follow up cohort in real life

Speaker: Doctor A. Garcia Quintana (Palmas de Gran Canaria, Las, ES)

Changes in glycated hemoglobin in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan

Valsartan reduces level of soluble ST2 and left ventricle remodeling in patients with dual chamber pacemaker

Speaker: Mrs E. Radzik (Zabrze, PL)

Access the full session

Poster Session 1 - Treatment of the chronic heart failure

Speakers: Doctor S. Suzuki, Doctor A. Kozynacka, Doctor G. Benincasa, Doctor A. Garcia Quintana, Mrs E. Radzik

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources